BlackRock Fund Advisors’s NanoViricides NNVC Stock Holding History

BlackRock Fund Advisors’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$124K	Buy	5,788 +187	+3%	+$4.99K	﹤0.01%	3552
2016 Q3	$189K	Sell	5,601 -5	-0.1%	-$166	﹤0.01%	3473
2016 Q2	$179K	Sell	5,606 -102	-2%	-$3.72K	﹤0.01%	3493
2016 Q1	$250K	Sell	5,708 -455	-7%	-$17.7K	﹤0.01%	3392
2015 Q4	$145K	Buy	6,163 +214	+4%	+$5.13K	﹤0.01%	3636
2015 Q3	$142K	Sell	5,949 -157	-3%	-$4.15K	﹤0.01%	3603
2015 Q2	$211K	Sell	6,106 -53,902	-90%	-$2.05M	﹤0.01%	3511
2015 Q1	$2.7M	Buy	60,008 +1,010	+2%	+$53.9K	﹤0.01%	3071
2014 Q4	$3.21M	Buy	58,998 +11,628	+25%	+$770K	﹤0.01%	3058
2014 Q3	$2.84M	Sell	47,370 -1,961	-4%	-$154K	﹤0.01%	3045
2014 Q2	$4.17M	Buy	+49,331	New	+$3.5M	﹤0.01%	2936

Other funds holding NNVC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

SCA

STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.36B AUM 23.72% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

PTB

Pioneer Trust Bank Salem, Oregon $412M AUM 17.77% 1-Year Est. Return

BlackRock Fund Advisors's NNVC Position: Q4 2016 in Review

BlackRock Fund Advisors increased its NanoViricides (NNVC) stake by 3.3% in Q4 2016, buying an estimated $4.99K and bringing the position to 5,788 shares worth $124K. The position accounts for ﹤0.01% of the portfolio, ranked #3552.

BlackRock Fund Advisors first reported a position in NNVC in Q2 2014 and has held it in 11 quarters since. The position peaked at $4.17M in Q2 2014. 44 funds tracked by Wall St. Rank hold NNVC as of Q4 2016.

BlackRock Fund Advisors held 5,788 shares of NanoViricides worth $124K as of Q4 2016.
BlackRock Fund Advisors bought 187 NanoViricides shares in Q4 2016, an estimated $4.99K.
NanoViricides made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3552 holding.
BlackRock Fund Advisors first reported a position in NanoViricides in Q2 2014 and has held it in 11 quarters since.
BlackRock Fund Advisors's NanoViricides position peaked at $4.17M in Q2 2014.
44 funds tracked by Wall St. Rank held NanoViricides as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.